Amgen Inc (USD)
AMGN
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range209.82 | 219.56
52-Wk Range166.30 | 244.99
Last Close217.88
Mkt Cap (m)128,507.11
Dividend yield2.73%
ISINUS0311621009
Volume3,868,507
Exchange VenueNAS

Company Profile

Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.

Key Information
Price/Earning16.92
Price/Book13.28
Price/Sales5.68
P/CF14.50
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-
Debt/Equity-

Documents

Prospectus
en 20/02/2020
Annual Report
en 31/12/2019

Financials

Income Statement
USD201420152016201720182019
Revenue (m)20,06321,66222,99122,84923,747-
Operating Income (m)6,1918,4709,7949,97310,263-
Net Income (m)5,1586,9397,7221,9798,394-
Basic EPS6.809.1510.322.7112.70-
Avg. Diluted Shares Outstanding (m)770766754735665-
Balance Sheet
USD201420152016201720182019
Current Assets (m)34,71338,51846,01049,47637,618-
Non Current Assets (m)34,29633,05831,61630,47828,798-
Total Assets (m)69,00971,57677,62679,95466,416-
Current Liabilities (m)7,0088,66711,2049,02013,488-
Total Liabilities (m)------
Total Equity (m)25,77828,08329,87525,24112,500-
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)8,5559,07710,35411,17711,296-
Capital Expenditure (m)-1,003-649-837-664-738-
Figures are quoted in USD unless stated otherwise
-7.50 (-3.44%)
$
210.38
Last Price